Eaton Financial Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$887K Sell
739
-41
-5% -$41.9K 0.24% 70
2026
Q1
$717K Sell
780
-137
-15% -$139K 0.23% 77
2025
Q4
$986K Sell
917
-2
-0.2% -$1.91K 0.27% 67
2025
Q3
$701K Sell
919
-6
-0.6% -$4.46K 0.2% 78
2025
Q2
$721K Buy
+925
New +$719K 0.22% 65
2023
Q4
Sell
-989
Closed -$531K 165
2023
Q3
$531K Buy
989
+24
+2% +$12.4K 0.14% 121
2023
Q2
$453K Buy
965
+25
+3% +$10.5K 0.34% 39
2023
Q1
$323K Hold
940
0.25% 43
2022
Q4
$344K Buy
+940
New +$333K 0.29% 50

Other funds holding LLY

Eaton Financial Holdings's LLY Position: Q2 2026 in Review

Eaton Financial Holdings reduced its Eli Lilly (LLY) stake by 5.3% in Q2 2026, selling an estimated $41.9K and leaving 739 shares worth $887K. The position accounts for 0.24% of the portfolio, ranked #70.

Eaton Financial Holdings first reported a position in LLY in Q4 2022 and has held it in 9 quarters since. The position peaked at $986K in Q4 2025. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Eaton Financial Holdings held 739 shares of Eli Lilly worth $887K as of Q2 2026.
  • Eaton Financial Holdings sold 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 0.24% of Eaton Financial Holdings's portfolio in Q2 2026, its #70 holding.
  • Eaton Financial Holdings first reported a position in Eli Lilly in Q4 2022 and has held it in 9 quarters since.
  • Eaton Financial Holdings's Eli Lilly position peaked at $986K in Q4 2025.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eaton Financial Holdings's 13F filing for Q2 2026, filed 5 Aug 2026.